PA8563501A1 - Acidos 3-(imidazolil)-2-alcoxipropanoicos - Google Patents

Acidos 3-(imidazolil)-2-alcoxipropanoicos

Info

Publication number
PA8563501A1
PA8563501A1 PA20038563501A PA8563501A PA8563501A1 PA 8563501 A1 PA8563501 A1 PA 8563501A1 PA 20038563501 A PA20038563501 A PA 20038563501A PA 8563501 A PA8563501 A PA 8563501A PA 8563501 A1 PA8563501 A1 PA 8563501A1
Authority
PA
Panama
Prior art keywords
rent
hydrogen
alcoxipropanoicos
imidazolil
acids
Prior art date
Application number
PA20038563501A
Other languages
English (en)
Spanish (es)
Inventor
Mark Edward Bunange
Allerton Charlotte Moira Norfor
John Steele
David John Bull
Robert John Maguire
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0201389A external-priority patent/GB0201389D0/en
Priority claimed from GB0202027A external-priority patent/GB0202027D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of PA8563501A1 publication Critical patent/PA8563501A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PA20038563501A 2002-01-22 2003-01-22 Acidos 3-(imidazolil)-2-alcoxipropanoicos PA8563501A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0201389A GB0201389D0 (en) 2002-01-22 2002-01-22 3-(imidazolyl)-2-alkoxypropanoic acids
GB0202027A GB0202027D0 (en) 2002-01-29 2002-01-29 3-(imidazolyl)-2-alkoxypropanoic acids

Publications (1)

Publication Number Publication Date
PA8563501A1 true PA8563501A1 (es) 2004-08-31

Family

ID=27614792

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20038563501A PA8563501A1 (es) 2002-01-22 2003-01-22 Acidos 3-(imidazolil)-2-alcoxipropanoicos

Country Status (24)

Country Link
EP (1) EP1467731A1 (fr)
JP (1) JP2005520811A (fr)
KR (1) KR20040077775A (fr)
CN (1) CN1620291A (fr)
AP (1) AP2004003084A0 (fr)
AR (1) AR038197A1 (fr)
BR (1) BR0307016A (fr)
CA (1) CA2472238A1 (fr)
EA (1) EA200400716A1 (fr)
EC (1) ECSP045200A (fr)
HR (1) HRP20040659A2 (fr)
IL (1) IL162677A0 (fr)
IS (1) IS7310A (fr)
MA (1) MA27167A1 (fr)
MX (1) MXPA04006573A (fr)
NO (1) NO20043457L (fr)
OA (1) OA12756A (fr)
PA (1) PA8563501A1 (fr)
PE (1) PE20030929A1 (fr)
PL (1) PL371487A1 (fr)
TN (1) TNSN04121A1 (fr)
TW (1) TW200302094A (fr)
UY (1) UY27615A1 (fr)
WO (1) WO2003061652A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005051384A1 (fr) * 2003-11-25 2005-06-09 Pfizer Limited Compositions pharmaceutiques stabilisees
EP1874322A1 (fr) * 2005-04-18 2008-01-09 Bayer Schering Pharma Aktiengesellschaft Utilisation d'inhibiteurs de tafi pour ameliorer la reperfusion myocardique et faciliter la pci
AU2009310841A1 (en) 2008-10-29 2010-05-06 Taisho Pharmaceutical Co., Ltd. Compounds having TAFIa inhibitory activity
WO2010065717A1 (fr) * 2008-12-05 2010-06-10 Mochida Pharmaceutical Co., Ltd. Composés de morpholinone en tant qu'inhibiteurs de facteur ixa
US8987242B2 (en) 2008-12-05 2015-03-24 Merck Sharp & Dohme Corp. Morpholinone compounds as factor IXA inhibitors
MX358628B (es) * 2010-03-18 2018-08-28 Daiichi Sankyo Co Ltd Derivado de imidazol sustituido con cicloalquilo.
WO2011115065A1 (fr) 2010-03-18 2011-09-22 第一三共株式会社 Dérivé d'acide cyclopropanecarboxylique
CN105263928A (zh) 2013-06-10 2016-01-20 赛诺菲 作为TAFIa的抑制剂的大环脲衍生物、其制备及其作为药物的用途
WO2017170460A1 (fr) 2016-03-29 2017-10-05 第一三共株式会社 Agent thérapeutique contre les maladies inflammatoires de l'intestin
EP3682881A4 (fr) 2017-09-14 2021-08-11 Daiichi Sankyo Company, Limited Composé à structure cyclique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9901572D0 (sv) * 1999-05-03 1999-05-03 Astra Ab New compounds
EE200300070A (et) * 2000-08-17 2005-02-15 Pfizer Inc. Asendatud imidasoolid kui TAFIa inhibiitorid

Also Published As

Publication number Publication date
CA2472238A1 (fr) 2003-07-31
HRP20040659A2 (en) 2004-10-31
UY27615A1 (es) 2003-08-29
EA200400716A1 (ru) 2004-12-30
ECSP045200A (es) 2004-08-27
OA12756A (en) 2006-07-03
MXPA04006573A (es) 2004-10-04
IL162677A0 (en) 2005-11-20
KR20040077775A (ko) 2004-09-06
MA27167A1 (fr) 2005-01-03
AR038197A1 (es) 2005-01-05
PL371487A1 (en) 2005-06-13
PE20030929A1 (es) 2003-11-05
NO20043457L (no) 2004-08-19
TW200302094A (en) 2003-08-01
WO2003061652A8 (fr) 2004-09-10
BR0307016A (pt) 2004-11-03
CN1620291A (zh) 2005-05-25
WO2003061652A1 (fr) 2003-07-31
EP1467731A1 (fr) 2004-10-20
JP2005520811A (ja) 2005-07-14
IS7310A (is) 2004-06-14
AP2004003084A0 (en) 2004-09-30
TNSN04121A1 (en) 2006-06-01

Similar Documents

Publication Publication Date Title
CY1107903T1 (el) Παραγωγα ακυλαμινοθειαζολης και η χρηση τους ως αναστολεις του βητα-αμυλοειδους
EA200500017A1 (ru) Новые соединения
CR20120152A (es) Derivados de 3-aminopirrolidina como moduladores de receptores de quimocina
PE20060777A1 (es) Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
DE602005003960D1 (en) Oximesther-fotoinitiatoren
PE20070218A1 (es) COMPUESTOS DE CICLOALQUILO AMINO-HIDANTOINA Y USO DE ESTOS PARA LA MODULACION DE ß-SECRETASA
ATE404538T1 (de) Tetrahydropyranylcyclopentyltetrahydroisochino- linmodulatoren der chemokinrezeptoraktivität
PE20071321A1 (es) Bencensulfonil-cromano, tiocromano, tetrahidronaftaleno e inhibidores de gamma secretasa relacionados
HUP0402376A2 (hu) Imidazol-4-karboxamid-származékok, előállításuk és az ezeket tartalmazó, elhízás kezelésére alkalmas gyógyszerkészítmények
CO5611139A2 (es) Pirimidinas aril sustituidas y el uso de las mismas
PE20061325A1 (es) Derivados de pirrolidina como inhibidores de la renina
AR039489A1 (es) Derivados de tetrahidropiranil ciclopentil tetrahidropiridopiridina, moduladores de actividad de receptores de citoquinas
ATE361922T1 (de) Pyrrol-substituierte indole als inhibitoren von pai-1
PE20060977A1 (es) Derivados de piperidinilo como bloqueantes de canales de calcio
ATE446753T1 (de) Verwendung von substituierten 2-thio-3,5-dicyano- 4-phenyl-6-aminopyridinen bei der behandlung von übelkeit und erbrechen
PA8563601A1 (es) Acidos-3-(imidazolil)-2- alcoxipropanoicos
ECSP099065A (es) Derivados de cinamoil-piperazina y su utilización como antagonistas de par-1
DE60214990D1 (de) Benzolsulfonsäureester-indol-5-yl als 5-ht6 rezeptor-antagonisten
PA8563501A1 (es) Acidos 3-(imidazolil)-2-alcoxipropanoicos
PE20050226A1 (es) Productos aril-heteroaromaticos y composiciones que los contienen
PE20071040A1 (es) Derivados de 8-azabiciclo[3.2.1]octano como inhibidores de la recaptacion de monoaminas
AR042362A1 (es) Derivados de 3h-quinazolin-4-ona, proceso de obtencion y composiciones farmaceuticas que los contienen
DE602004006118D1 (de) 2,3,4,5-TETRAHYDROBENZOiFöi1,4öOXAZEPIN-5-CARBONSÄUREAMID DERIVATE ALS GAMMA-SECRETASE INHIBITOREN ZUR BEHANDLUNG VON ALZHEIMER
PE20011262A1 (es) Combinacion de secretagogos de hormona del crecimiento y antidepresivos
RS115804A (en) Pyrrolidine derivatives as oxytocin antagonists